TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2024
Back to search
Official data from USPTO
AXXINOVAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
09/12/2024
Trademark type
Combined
Nice classes
5, 35, 42
Filing date
08/22/2022
Registration date
01/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2024
Last transaction
09/12/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
01
Owner location
IN
Examiner
SOUDERS, MICHAEL
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
J. D. (pessoa física)
Representatives
Louis J. Levy Symbus Law Group PLLC
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal and pharmaceutical preparations for use in the syndromic approach for treating painheadachefevercoughsshockdehydrationhypoglycemiaoral and dental conditionsgastrointestinal conditionsrespiratory diseaseobstetrical/gynecological conditionscardiovascular diseaseskin diseasesallergic reactionsmusculo-skeletal and joint diseaseskidney and urological disordersotolaryngological diseaseseye diseasesneurological system diseasesmetabolic and endocrinological diseaseshematological diseasesmalignant diseasesprotozoal infections and conditionssexually transmitted infectionsHIV and other viral infectionsnutritional disorders and poisoning; pharmaceutical preparationscontraceptive preparations
Class 35
Providing advertisingmarketing and promotional services for the pharmaceutical and medical industry; wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; providing advertisingmarketing and promotional services for the pharmaceutical and medical products of others
Class 42
Scientific and medical research and development in the fields of medicinesdiagnostic aids and radio-pharmaceuticals for the treatment of painheadachesfeverscoughsshockdehydrationhypoglycemiaoral and dental conditionsgastrointestinal conditionsrespiratory conditionsobstetrical/gynecological conditions and contraceptioncardiovascular conditionsskin diseases and allergic reactionsmusculo-skeletal and joint conditionskidney and urological disordersotolaryngological diseaseseye conditionsneurological conditionsmetabolic and endorcinological conditionshematological conditionstrauma and injuriesmalignant disease conditionsmalariatuberculosisleprosysexually transmitted infectionsHIV and other viral infections and conditionsprotozoa infections and conditionspoisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
28 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/08/2024
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/22/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/01/2024
FIMP
FINAL DISPOSITION PROCESSED
05/01/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/30/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/14/2023
PUBO
PUBLISHED FOR OPPOSITION
11/14/2023
GPNX
NOTIFICATION PROCESSED BY IB
11/13/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/25/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2023
RFNT
REFUSAL PROCESSED BY IB
08/15/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/24/2023
RFRR
REFUSAL PROCESSED BY MPU
07/24/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/17/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/17/2023
CNRT
NON-FINAL ACTION WRITTEN
06/16/2023
DOCK
ASSIGNED TO EXAMINER
06/13/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/13/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/08/2023
Continuous trademark protection
Get notified about every new filing that threatens AXXINOVAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.